BR9709812A - Processo para prevencão e tratamento de mastites - Google Patents

Processo para prevencão e tratamento de mastites

Info

Publication number
BR9709812A
BR9709812A BR9709812A BR9709812A BR9709812A BR 9709812 A BR9709812 A BR 9709812A BR 9709812 A BR9709812 A BR 9709812A BR 9709812 A BR9709812 A BR 9709812A BR 9709812 A BR9709812 A BR 9709812A
Authority
BR
Brazil
Prior art keywords
micrococcin
infection
mastitis
treatment
antibiotics
Prior art date
Application number
BR9709812A
Other languages
English (en)
Inventor
Bruno Suri
Catherine Georges
John Edmondson Peel
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BR9709812A publication Critical patent/BR9709812A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C19/00Cheese; Cheese preparations; Making thereof
    • A23C19/02Making cheese curd
    • A23C19/05Treating milk before coagulation; Separating whey from curd
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05Dipeptides
BR9709812A 1996-06-20 1997-06-19 Processo para prevencão e tratamento de mastites BR9709812A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96810415 1996-06-20
PCT/EP1997/003212 WO1997048408A2 (en) 1996-06-20 1997-06-19 Method for the prevention and treatment of mastitis

Publications (1)

Publication Number Publication Date
BR9709812A true BR9709812A (pt) 1999-08-10

Family

ID=8225635

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9709812A BR9709812A (pt) 1996-06-20 1997-06-19 Processo para prevencão e tratamento de mastites

Country Status (14)

Country Link
US (1) US6187800B1 (pt)
EP (1) EP0934075B1 (pt)
JP (1) JP2000513348A (pt)
CN (1) CN1119170C (pt)
AT (1) ATE215378T1 (pt)
AU (1) AU720243B2 (pt)
BR (1) BR9709812A (pt)
CA (1) CA2251779A1 (pt)
DE (1) DE69711661T2 (pt)
DK (1) DK0934075T3 (pt)
ES (1) ES2175425T3 (pt)
IL (1) IL126489A0 (pt)
PT (1) PT934075E (pt)
WO (1) WO1997048408A2 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035107A1 (en) * 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
US6638902B2 (en) * 2001-02-01 2003-10-28 Ecolab Inc. Stable solid enzyme compositions and methods employing them
US7030085B2 (en) 2001-03-13 2006-04-18 Astellas Pharma Inc Thiopeptide compounds
DE10161077A1 (de) * 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
CN1226998C (zh) * 2002-06-28 2005-11-16 陈放 可控释型奶道栓
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1568369A1 (en) * 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
NZ539076A (en) * 2005-03-29 2008-05-30 Blis Technologies Ltd Skin treatment compositions
CN100368016C (zh) * 2005-04-01 2008-02-13 北京大北农农业科技研究院 治疗奶牛乳房炎的乳房灌注液及其制备方法
CA2623201A1 (en) * 2005-09-30 2007-04-12 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical preparation containing meloxicam
CN100448480C (zh) * 2005-11-09 2009-01-07 北京大北农科技集团股份有限公司 治疗奶牛乳房炎的乳房用无菌粉针制剂及其制备方法
US7906138B2 (en) * 2006-10-10 2011-03-15 Wisconsin Alumni Research Foundation Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses
EP2416787B1 (en) 2009-04-08 2015-10-21 Wisconsin Alumni Research Foundation Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses
WO2011046853A1 (en) 2009-10-12 2011-04-21 Boehringer Ingelheim Vetmedica Gmbh Containers for compositions comprising meloxicam
EP2361632B1 (en) * 2010-02-19 2014-03-19 Protectimmun GmbH Specific environmental bacteria for the protection from and/or the treatment of allergic, chronic inflammatory and/or autoimmune diseases
WO2011107150A1 (en) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
CA2900373C (en) * 2013-02-08 2021-02-16 Luoda Pharma Pty Ltd Methods of treating microbial infections, including mastitis
WO2014121342A1 (en) * 2013-02-08 2014-08-14 Luoda Pharma Pty Limited Methods of treating topical microbial infections
TW201607534A (zh) * 2013-10-31 2016-03-01 皮拉馬爾企業有限公司 治療困難梭狀芽孢桿菌相關感染用硫肽化合物
EP3541349B1 (en) * 2016-12-27 2022-11-16 Colgate-Palmolive Company Antiperspirant or deodorant composition for use in reducing il-1alpha release and skin irritability
GB202014427D0 (en) * 2020-09-14 2020-10-28 Norwegian Univ Of Life Sciences Composition and use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5710124A (en) 1993-08-20 1998-01-20 Novartis Corporation Method for combatting bovine mastitis

Also Published As

Publication number Publication date
EP0934075B1 (en) 2002-04-03
WO1997048408A2 (en) 1997-12-24
WO1997048408A3 (en) 1998-02-19
JP2000513348A (ja) 2000-10-10
ATE215378T1 (de) 2002-04-15
AU3341097A (en) 1998-01-07
US6187800B1 (en) 2001-02-13
PT934075E (pt) 2002-08-30
CA2251779A1 (en) 1997-12-24
DE69711661T2 (de) 2002-10-17
AU720243B2 (en) 2000-05-25
IL126489A0 (en) 1999-08-17
DE69711661D1 (de) 2002-05-08
DK0934075T3 (da) 2002-06-10
ES2175425T3 (es) 2002-11-16
CN1222081A (zh) 1999-07-07
EP0934075A2 (en) 1999-08-11
CN1119170C (zh) 2003-08-27

Similar Documents

Publication Publication Date Title
BR9709812A (pt) Processo para prevencão e tratamento de mastites
ATE277638T1 (de) Zubereitungen zur behandlung von gastrointestinalen störungen, welche arabinogalactan und polyphenole von larix enthalten.
MY113059A (en) Controlled-release dosage forms of azithromycin
ES2178656T3 (es) Metodo para tratar infeccion bacteriana gram-negativa por administracion de productos de proteina bactericida que aumenta la permebilidad(bpi) y antibioticos.
MY118641A (en) Method of preventing, countering or reducing chronic gastrointestinal disorders or nsaid-induced gastrointestinal damage
Owens et al. Efficacy of parenterally or intramammarily administered tilmicosin or ceftiofur against Staphylococcus aureus mastitis during lactation
ATE223649T1 (de) Mittel zum eintauchen von zitzen
SE9301994L (sv) Framställning av steril mjölk
ATE201995T1 (de) Verfahren zur prävention und behandlung der rindermastitis
NZ509605A (en) Cheese ripening process using an attenuated bacterial starter culture obtained by treatment with a surface active agent
ATE279939T1 (de) Phytase zur vorbeugung oder behandlung von mastitis
WO2003103699A8 (en) USE OF RAMOPLANIN TO TREAT DISORDERS ASSOCIATED WITH THE TAKING OF ANTIBIOTICS
WO2004071324A3 (en) Method to reduce, eliminate, or prevent bacterial pathogen colonization in eggs and/or poultry using bacteriophages
Oliver et al. Intramammary infections in heifers during early lactation following intramammary infusion of pirlimycin hydrochloride or penicillin-novobiocin at the first milking after parturition
NZ503145A (en) 8a-Azalides as veterinary antimicrobial agents to treat bacterial respiratory infection
WO2006014619A1 (en) Methods for prevention and treatment of mastitis
MX2021012375A (es) Metodo para tratar y prevenir infecciones oseas y de articulaciones.
DE60222298D1 (de) Verfahren zur behandlung von bakteriellen infektionen mit gemifloxacin oder einem seiner salze und einem beta-lactam-antibiotikum
DE3772255D1 (de) Behandlungsverfahren fuer milch zur erhaltung von kaese.
Hogan et al. Efficacy of parenteral vitamin E for treating bovine mastitis
WO1999000140A3 (en) Accelerating animal hoof growth with somatotropin
Žilaitis et al. Effect of low intensity laser radiation on cow’s milk microflora and somatic cell count
Hogan et al. Efficacy of Dry Cow Therapy and a Propionibacterium acnes Product in Low Somatic Cell Count Herds
Podpečan et al. Amoxicillin concentrations in bovine milk following different prolonged treatment protocols and their influence on maximum residue levels.[Conference poster].
UA33121A (uk) Спосіб лікування маститу у корів

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements